The New York Times 2004 Barnaby J. Feder |
Title | Subject | Authors |
Criticism of Drug May Leave Pfizer Awash in Lawsuits.(Business/Financial Desk)(PFIZER AND CELEBREX: THE COMPANY) | News, opinion and commentary | Barnaby J. Feder |
Doctors Use Nanotechnology to Improve Health Care.(Business/Financial Desk)(TECHNOLOGY) | News, opinion and commentary | Barnaby J. Feder |
Even as Insurers Balk, Surgeons in U.S. Start Implanting Artificial Disks.(Business/Financial Desk)(An Alternative to Spinal Fusion) | News, opinion and commentary | Barnaby J. Feder |
Johnson & Johnson Decides It Needs Devices.(Business/Financial Desk)(THE MARKETS: MARKET PLACE) | News, opinion and commentary | Barnaby J. Feder |
Johnson Said To Be in Talks For Heart Device Maker.(Business/Financial Desk) | News, opinion and commentary | Andrew Ross Sorkin, Barnaby J. Feder |
KPMG Units Agree to Pay To Settle Malpractice Suits.(Business/Financial Desk) | News, opinion and commentary | Barnaby J. Feder |
Latest MyDoom Worm Plagues Search Sites.(Business/Financial Desk) | News, opinion and commentary | Barnaby J. Feder |
Lawyers Organizing for Mass Suits Over Vioxx.(Business/Financial Desk) | News, opinion and commentary | Barnaby J. Feder |
New Chief to Take Reins as Motorola Takes on Challenge of Rivals.(Business/Financial Desk) | News, opinion and commentary | Barnaby J. Feder |
One Stent Maker Thrives as Rival Gets the Kudos.(Business/Financial Desk) | News, opinion and commentary | Barnaby J. Feder |
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.